-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
PURE Bioscience (OTCMKTS:PURE) Share Price Passes Above Two Hundred Day Moving Average of $0.19
PURE Bioscience (OTCMKTS:PURE) Share Price Passes Above Two Hundred Day Moving Average of $0.19
PURE Bioscience, Inc. (OTCMKTS:PURE – Get Rating)'s stock price passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.19 and traded as high as $0.23. PURE Bioscience shares last traded at $0.23, with a volume of 114,685 shares.
PURE Bioscience Price Performance
The firm has a market capitalization of $20.24 million, a price-to-earnings ratio of -5.75 and a beta of 0.02. The business's fifty day simple moving average is $0.20 and its 200 day simple moving average is $0.19.
Get PURE Bioscience alerts:PURE Bioscience (OTCMKTS:PURE – Get Rating) last issued its quarterly earnings data on Tuesday, June 14th. The company reported ($0.01) earnings per share (EPS) for the quarter. The business had revenue of $0.50 million for the quarter. PURE Bioscience had a negative net margin of 131.59% and a negative return on equity of 131.39%.
About PURE Bioscience
(Get Rating)PURE Bioscience, Inc develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds.
Recommended Stories
- Get a free copy of the StockNews.com research report on PURE Bioscience (PURE)
- Could Snap Stock Rebound As Management Restructures?
- MarketBeat: Week in Review 8/29 – 9/2
- Hormel Looks Cheap At These Levels
- Lululemon Set To Soar Into September
- Could Nike Stock be Oversold, but Still Overvalued?
Receive News & Ratings for PURE Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PURE Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
PURE Bioscience, Inc. (OTCMKTS:PURE – Get Rating)'s stock price passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.19 and traded as high as $0.23. PURE Bioscience shares last traded at $0.23, with a volume of 114,685 shares.
Pure Bioscience,Inc.(OTCMKTS:Pure-Get Rating)的股價在週五的交易中超過了200日移動均線,200日移動均線為0.19美元,最高交易價格為0.23美元。Pure Bioscience的股票最新報0.23美元,成交量為114,685股。
PURE Bioscience Price Performance
純生物科學性價比
The firm has a market capitalization of $20.24 million, a price-to-earnings ratio of -5.75 and a beta of 0.02. The business's fifty day simple moving average is $0.20 and its 200 day simple moving average is $0.19.
該公司市值為2,024萬美元,市盈率為-5.75倍,貝塔係數為0.02。該業務的50日簡單移動均線切入位為0.20美元,200日簡單移動均線切入位為0.19美元。
PURE Bioscience (OTCMKTS:PURE – Get Rating) last issued its quarterly earnings data on Tuesday, June 14th. The company reported ($0.01) earnings per share (EPS) for the quarter. The business had revenue of $0.50 million for the quarter. PURE Bioscience had a negative net margin of 131.59% and a negative return on equity of 131.39%.
Pure Bioscience(OTCMKTS:Pure-Get Rating)最近一次發佈季度收益數據是在6月14日(星期二)。該公司公佈了該季度每股收益(EPS)(0.01美元)。該業務本季度的收入為50萬美元。純生物科學公司的淨利潤率為負131.59%,淨資產回報率為負131.39%。
About PURE Bioscience
關於純生物科學
PURE Bioscience, Inc develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds.
Pure Bioscience公司開發和商業化抗菌產品,為美國和國際上病原體的健康和環境挑戰以及衞生控制提供解決方案。該公司製造和分銷檸檬酸二氫銀(SDC),這是一種無毒的抗菌劑,可提供殘留保護,並與其他化合物一起配製。
Recommended Stories
推薦故事
- Get a free copy of the StockNews.com research report on PURE Bioscience (PURE)
- Could Snap Stock Rebound As Management Restructures?
- MarketBeat: Week in Review 8/29 – 9/2
- Hormel Looks Cheap At These Levels
- Lululemon Set To Soar Into September
- Could Nike Stock be Oversold, but Still Overvalued?
- 免費獲取StockNews.com關於純生物科學的研究報告(PURE)
- 隨着管理層重組,股市能否迅速反彈?
- MarketBeat:回顧中的一週8/29-9/2
- 霍梅爾在這些水平上看起來很便宜
- 露露檸檬將飆升至9月
- 耐克股票會被超賣,但仍被高估嗎?
Receive News & Ratings for PURE Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PURE Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
獲得《純生物科學日報》的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Pure Bioscience和相關公司的最新新聞和分析師評級的每日簡要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧